Sunday, September 4, 2011

Toothless Grins Are Only Cute on Babies

Dental injuries are all too common among young athletes, especially those playing basketball and baseball, an expert says.

"Basketball and baseball are the two biggest mouth-injuring sports. And the most common injuries we see are broken, displaced or knocked out teeth, and broken jaws," Dr. Stephen Mitchell, an associate professor in the pediatric dentistry department at the University of Alabama at Birmingham, said in a university news release.

It's estimated that more than 3 million teeth will be knocked out in youth sporting events in the United States this year, according to the National Youth Sports Safety Foundation.

Mouth guards and helmets with face protectors can help reduce young athletes' risk of dental injuries.

"If the child has a full set of permanent teeth then a custom guard can be made that will provide protection but be small enough to make it easy to communicate with teammates," Mitchell said. "But if they still have some of their baby teeth, a custom guard is a waste of money. Parents will be better off going to the store and buying one of the guards that can be boiled and molded to their child's mouth."

If a child does suffer a broken or cracked tooth, see a dentist within 24 hours. If a child loses a tooth or teeth, immediately go to the emergency department and try to preserve the tooth/teeth.

"A tooth that has been knocked out needs to be back in the mouth within 30 minutes for the best chance of long-term survival," Mitchell said.

If your child is old enough not to swallow the tooth, you can try to gently place the tooth back in its socket. If that's not possible, place the tooth in milk. Don't put it in water and don't handle it by the root, which is easily damaged, Mitchell advised.

Making Sure 'Back to School' Doesn't Mean 'Back to Bullying'

For some children, the start of school means the beginning of bullying.

Despite widespread efforts to deal with the problem, bullying is a persistent issue in schools, says Donna Henderson, a professor of counseling at Wake Forest University in Winston-Salem, N.C.

"The goal is to create a no-bullying environment for children. It's hard because we live in a world that accepts violence, intimidation and power as currency in life," Henderson said in a university news release.

Henderson offered tips for parents to prevent their children from becoming bullies or victims:

  • Ask school officials and teachers about what they do to prevent bullying and hold schools accountable for their anti-bullying policies.
  • Watch for warning signs in children at the start of the new school year, such as sudden changes in behavior and not eating.
  • When you see bullying behavior, call it bullying and tell your children that it's unacceptable behavior.
  • Discuss bullying with your children. Use real situations, news stories, television programs and movies as opportunities to talk about bullying.
  • Regularly ask children about bullying and address any problem immediately.
  • If your child is being bullied, letting them know you understand and share their distress can help them feel better.
  • Discuss and/or role play possible responses to bullying, such as walking away, not showing emotion, staying in groups to avoid being singled out, and confronting a bully.
  • Do some self-assessment. If you use intimidation in your dealings with others, you may be setting a bullying example for your child. Or if you're bullied by other adults and don't put a stop to it, your child will believe that's the way to respond to bullies.

Saturday, September 3, 2011

No shot, no doc: Pediatricians refuse unvaccinated kids

Fear that babies, too young for vaccines, may be infected by kids whose parents choose not to vaccinate

The story of Michayla Kubasiak, hospitalized at seven weeks old with whooping cough, may prompt parents to ask their pediatricians an important question: Does your office treat unvaccinated patients?

Michayla developed a cough that landed her in the pediatric intensive care unit for two weeks.

“It was terrifying, definitely terrifying,” her mother, Michelle Kubasiak,said

“She got better, she got worse. She got better, she got worse. They found that she did have
pertussis -- whooping cough.”

Little Michayla was vulnerable to the highly contagious disease, which is dangerous in infants and children, because at the time she was exposed she wasn’t old enough for the pertussis vaccine.

The fact that she may have been exposed in her pediatrician’s office by an unvaccinated patient was one reason her doctor’s office recently imposed a policy requiring all patients to be immunized.

“We believe it is medically appropriate to exclude unvaccinated children from a pediatric practice to protect the vaccinated children from communicable infectious diseases,” read a letter her doctors sent to their patients.

The practice is part of a small but growing controversial trend of pediatricians dropping patients whose parents refuse to allow their children to be vaccinated. The American Academy of Pediatrics, which supports universal immunization, says refusal to immunize should not be the only reason a doctor turns a family away.

“In general, pediatricians should avoid discharging patients from their practices solely because a parent refuses to immunize his or her child,” the group says in a report. “However, when a substantial level of distrust develops, significant differences in the philosophy of care emerge, or poor quality of communication persists, the pediatrician may encourage the family to find another physician or practice.”

Dr. Douglas Diekema, lead author of the academy’s report, told

: “I think we have to be really careful about refusing to take care of the kids simply because their parents may make decisions that we don't always agree with.”

While there may be no greater regularly scheduled anguish for parents than watching their infants and toddlers being held down to get shots, the medical and scientific community calls them safe and effective lifesavers.

Still, some parents refuse some or all vaccines for their children for various reasons, including a belief that they cause autism, and some long-forgotten diseases are now becoming threats again. The Institute of Medicine released a safety review last month that found no link with autism, reiterating earlier studies that have looked at hundreds of thousands of children.

On one hand, doctors are there to treat everyone, and turning patients away leaves them still unvaccinated and without care. But, she added, an unvaccinated child who is carrying a virus is “literally a walking Typhoid Mary” who puts other children in a waiting room at risk.

Snyderman says vaccines have worked so well in combating disease that they’ve
almost become victims of their own success, as most moms and dads today don’t know what it’s like to suffer from diseases like measles.

Today’s parents “have never seen polio,” she said. “They don’t think pertussis is going to hit their kid.
“But if we don’t vaccinate, those are exactly the problems we’re going to see,” Snyderman told

“I worry that things like polio could be around the corner.”

The children most at risk from contracting a disease from an unvaccinated child in a waiting room are infants who have not yet received all of their shots and kids with compromised immune systems from conditions like cancer and HIV, said Dr. Carrie Byington, vice chair of the American Academy of Pediatrics' committee on infectious diseases. Some children with compromised immune systems are unable to be vaccinated, while others may develop a condition after being immunized that renders the vaccine ineffective, she said.

But parents with older healthy kids whose vaccines are up to date don’t have much to worry about, she said.

“A healthy child who’s fully immunized should be protected from exposure in waiting rooms to infectious diseases for which they are immunized,” she said.

Pediatrician Lisa Thornton says she worries about a possible rise in disease if parents don’t vaccinate because of the loss of herd immunity, which occurs when enough people in a population are vaccinated that a disease can’t move through a community.

To immunize or not remains an individual choice. For Kubasiak, whose daughter Michayla is now a healthy 7-year-old, the decision was an easy one.

“It's definitely not easy watching your child get three or four vaccinations in a visit and it's definitely something that's upsetting as a parent, but it's nothing like watching them be sick in a hospital,” Kubasiak told
“No comparison.”

FDA may get two more months to review new drugs

U.S. regulators and the drug industry want to extend by two months the deadline for the Food and Drug Administration to approve or reject new drugs. The extended timeline was tucked into the proposed deal the FDA forged with the prescription drug industry on the fees companies pay for drug reviews.

The FDA said it would need an extra 60-day "filing date" before the clock starts ticking on its 10-month deadline to review new drugs, or six months for a priority review.

The new five-year agreement, which will be put out for public comment, comes as the FDA faces increased criticism from congressional Republicans and the industry for being too slow in approving new products, which they say stifles innovation and job creation.

"People are kind of scratching their heads" over the longer review time, said an industry source familiar with the negotiations on the user fees.

"But the idea is that FDA will use those two months to really prepare for the review ... so the hope is that it gives us more predictability and makes everything shorter in the long-run."

The Prescription Drug User Fee Act (PDUFA), first enacted in 1992, gives the FDA millions of dollars annually to review new products for the U.S. market in exchange for quicker approvals and other promises.

Congress must reauthorize the current PDUFA legislation before it expires in September 2012. The FDA's new fee agreement with industry, which would kick in at the beginning of 2013, would be part of the reauthorization legislation .

MORE FEE FLEXIBILITY

The fees system is controversial, with some critics contending they influence the FDA, which is supposed to protect the health and safety of consumers.

Currently, about a third of the agency's funding comes from makers of drugs and medical devices -- and that could grow if the FDA reaches a final agreement with generic drugmakers.

In 2010, the FDA collected $922 million in user fees out of a total budget of about $3.28 billion. The agreement with the prescription drug industry would increase user fees 6 percent over levels in 2012 for an estimated total of about $713 million in 2013, FDA Commissioner Margaret Hamburg said in Congressional testimony in late July.

The FDA also wants more flexibility on how it spends the money. Some of the fees will go toward drug safety, rare diseases and for training FDA staff in new technologies and science -- part of a broader push to improve the agency's scientific expertise.

"If you look at the original PDUFA, all of that went directly to just review processes," said Ryan Hohman, the director for communications and policy at Friends of Cancer Research, a think-tank and advocacy group.

"But the FDA and industry stepped back and recognized that in the economic environment, they need to have the increase in science or else they won't be able to approve these drugs at a speedy time for patients."

Potatoes may help lower blood pressure. Purple ones, that is

Eating potatoes can benefit blood pressure without causing weight gain

Pity the potato. It's widely blamed for the fattening of America . But a small new study found that daily consumption of a certain type of potato -- purple ones, that is --- can help lower blood pressure, without causing weight gain.

The research, conducted by Joe Vinson, a chemistry professor at the University of Scranton in Pennsylvania, tracked 18 overweight or obese, hypertensive subjects who either ate six to eight small purple potatoes, with skins, at both lunch and dinner (for a daily total of 218 calories), or had no potatoes as part of their "normal" diet for four weeks. Then the participants crossed over to the other regimen.

On average, diastolic blood pressure -- the bottom number in a blood pressure reading -- dropped by a statistically significant 4.3 percent and systolic blood pressure -- the top number in a blood pressure reading -- dropped by 3.5 percent.

While eating potatoes, most of the subjects -- even those on anti-hypertensive medications -- experienced lower blood pressure, and none of the subjects gained weight.

Although less popular than their white counterparts, purple potatoes — increasingly available at supermarkets, specialty food stores and farmers' markets — boast higher levels of polyphenol antioxidants that protect body cells against free radical damage that can increase disease risk. To preserve these powerful plant chemicals, subjects in Vinson’s study were asked to microwave their potatoes instead of using other cooking methods.

While research from larger sample sizes is needed, Vinson says the findings "provide at least some evidence that eating potatoes might be preventative like drinking coffee to reduce blood pressure." He notes that, like coffee, potatoes are high in a specific polyphenol called chlorogenic acid that has been shown to lower blood pressure in mice.

The new research may help redeem the potato's nutritional rep. While a recent Harvard study found that having an extra daily serving of potatoes caused a small but significant weight gain (1 to 2 pounds) over a four year period, a closer look at the data reveals that weight gain from French fries was 6 times higher (3.35 pounds) than from boiled, baked, or mashed potatoes (0.6 pounds).

"The high cooking temperatures used to make French fries and potato chips seem to destroy most of the healthy substances in potatoes and leave mainly starch, fat and minerals," according to Vinson. Although the new study didn't include unfried red- and white-skinned potatoes, Vinson believes they will prove to produce similar body weight and blood pressure effects in future, larger human studies.

Indeed, potatoes can be a healthful addition to any diet, even if you’re trying to lose weight. They’re naturally low in calories, fat, cholesterol, and sodium, and rich in vitamins and minerals including vitamin C, an antioxidant that protects against cellular damage and potassium, a mineral that helps balance body fluids and negate possible blood pressure-raising effects of a high sodium diet. Potatoes also pack in fiber that may promote fullness and aid weight management.

To maximize possible nutritional and health benefits and minimize calories, lightly sauté, mash, or microwave potatoes instead of frying them and watch how you dress them. My favorite potatoes are red oven-roasted potatoes, cut in quarters, drizzled with extra virgin olive oil, some balsamic vinegar, and a pinch each of garlic and onion powder. Sweet potatoes cut into French fries and baked with a pinch of paprika and sea salt are also smart options.

Some recommendations for preparing potatoes from Jackie Newgent, R.D.,

  • Hash browns: Combine diced or sliced unpeeled potatoes with shallots and some chili pepper in a little olive oil. Cover first to steam, and then remove the lid, add garlic and scallions, and sauté until done. Finish with a handful of fresh herbs including parsley and rosemary.
  • Mashed potatoes: Keep potato skins on to maximize nutrients and add home-style appeal. For creamy moistness, use almond milk. Also add roasted garlic for extra flavor (and potential heart-heath benefits).
  • Baked or microwaved potatoes: Top with one pat of butter, a large dollop of plain Greek yogurt, and a generous amount of fresh chives or scallions. Or add zing with a dollop of tzatziki dip (a Greek dip made with yogurt, chopped cucumber, and mint).
  • Potato salad: For 2 pounds potatoes, use 4 tablespoons mayonnaise, 3 tablespoons stone-ground or Dijon mustard, 2 tablespoons plain Greek yogurt, and 1 tablespoon white wine vinegar. Serves 6.


Bad batteries in defibrillators tied to cardiac deaths


More than 1,000 deaths in 15 years linked to AED failures, new research finds


When Ralph Polanec collapsed June 25 at his Washington, D.C., gym, staff members thought they could save him with a shock from their automated external defibrillator. But when they tried to turn it on, nothing happened. The device didn’t even flicker. The gym’s staff later discovered that the AED’s batteries had been removed when they lost their charge — and had never been replaced.

That battery failure might have been Polanec’s death sentence. His heart never restarted, despite CPR from a friend and later treatment from emergency responders.

His stepmother, Ruth L. Polanec, was stunned when she learned the details of his death.

“He was just 55 years old,” said the 77-year-old Mesa, Ariz., woman. “He shouldn’t have died. I was very upset that the equipment wasn’t working, because if it had been working, it might have saved him. I just felt horrible that a young man should pass away when we have so much modern equipment today. But it’s no good if it doesn’t work.”

As it turns out, battery problems are one of the leading causes of potentially deadly AED failures, according to a new study published in the Annals of Emergency Medicine.

Some 1,150 deaths were tied to AED failures over a 15-year period, and nearly one in four of those failures was caused by problems with batteries, according to researchers who pored through nearly 41,000 reports of adverse events associated with the devices.

Problems with wiring and with the pads that attach to the patient’s chest accounted for other top concerns, said Dr. Lawrence A. DeLuca, the study’s lead author and an assistant professor of emergency medicine at the University of Arizona.

AEDs seem to be ubiquitous these days, popping up everywhere from fitness clubs and apartment complexes to airports and private homes. A recent survey by the independent market research publisher Kalorama Information suggested that AEDs for home use will be booming over the next couple of years — jumping more than 17 percent over the next couple of years. An estimated 1.5 million AEDs are sold a year, based on 2009 figures, according to Kalorama's research.

DeLuca was spurred to find out about the reliability of AEDs after having one fail on him.

Device malfunction spurred study
On vacation in the summer of 2008, DeLuca was summoned to use a defibrillator on a man who'd just gone into cardiac arrest. Two other vacationing doctors had been administering CPR when DeLuca arrived.

DeLuca grabbed the AED and put the pads on man’s chest. The device started to charge — and then suddenly went dead. Though there was a second AED at the resort, nine minutes had passed by the time the man received the shock that could have brought his heart back. DeLuca still blames the batteries for the man's death.

Those extra minutes may have made all the difference. Studies show that for every minute that passes after a cardiac arrest, the likelihood the heart will be restarted drops by 7 percent to 10 percent, DeLuca said.

After scrutinizing information in the FDA database logged between 1993 and 2008, Deluca and his colleagues determined that 23.2 percent of the AED failures were due to battery/power failures, while 23.7 percent were due to problems with the pads or connectors.

Even though the report describes a host of problems, DeLuca is quick to note that AED failures appear to be rare.

“I don’t want to send the message that these devices are unsafe or that they don’t work,” DeLuca said. “Most of the time they do work — and they save lives.”

Still, he’d like to see some changes that would make the devices more dependable — such as new designs that would allow device owners to connect AEDs to manufacturers’ computers to download new software and to run checks on the devices to make sure they’re in working order.

AED failures likely under-reported
Dr. John W. Hirshfeld Jr., says he suspects far more AEDs fail than are reported. Hirshfeld served on a recent FDA advisory panel that was asked to evaluate the defibrilators.

“These types of things do happen and they occur at some level of frequency that is disturbing,” said Hirshfeld, an interventional cardiologist and a professor of medicine at the University of Pennsylvania School of Medicine.

The FDA depends on AED users — often people who have no medical training — to recognize that they should report it when the devices fail. Many probably don’t know that they’re supposed to do this, Hirshfeld said.

“These are all tragic events, where everyone is dealing with the aftermath," he added. "Their first thought is not about telling the FDA about the problem.”

Even when people do report problems to the FDA, the accounts are often so vague that it’s hard to tell what went wrong, DeLuca said. He suggested that the agency could use a standardized form to collect information. The idea, he said, is to have a simple checklist of possible reasons for the device’s failure.

If the unit powers off, for instance, people can indicate whether the problem was due to the batteries or some other cause.

Batteries typically last anywhere from three to five years, DeLuca said. Still, things can go wrong. The best advice is to check the AED regularly and look for an error message that should alert users about low batteries.

Even that doesn’t guarantee safety, however. The device that failed on DeLuca had run a self test and reported that everything was OK.

For his part, DeLuca will always be haunted by the question of whether the man at the resort would have survived with a working AED.

“I thought it was the ideal situation,” he said. “The arrest had been witnessed by two physicians who started CPR immediately. The AED passed its self test. I was kneeling down beside him within three minutes of the time the arrest started. I can’t say for sure that this person would have lived even if it had worked, but…"


FDA and drugmakers agree to extend user fee plan

The Food and Drug Administration has agreed to work toward faster, more predictable reviews of new prescription drugs in return for millions of dollars in additional fees from drugmakers, under a draft agreement unveiled by the agency on Thursday.

A spokeswoman for the agency confirmed that the new agreement would raise fees about 6 percent, collecting an estimated $40.4 million in new revenue for fiscal year 2012.

The deal comes after months of closed-door meetings between FDA and drug industry officials working to extend a two-decade old program that supplements the agency's budget with company funding. The latest agreement would require the FDA to provide more meetings and updates on the status of certain drug reviews.

"We're starting to see a lot of innovative therapies come through as a result of all the investments in science over the last 30 years," said Dr. Janet Woodcock, director of the FDA's device center. "So this agreement will continue the review program that allows those products to move expeditiously through the regulatory process so they can reach the public in a timely way."

Some of the new revenue will also be invested in computers and technology for research, as well as a system for tracking reports of drug side effects. Currently the FDA tracks about 60 million patients across the U.S. through its Sentinel program, but agency officials say the network will need to be much larger to spot emerging drug safety risks.

The deal must be approved and drafted into law by Congress before it expires on Oct. 1 2012. Lawmakers already have granted three 5-year extensions to the program. Since it passed in 1992, the Prescription Drug User Fee Act has allowed the FDA to hire hundreds of additional scientists in return for meeting certain performance goals.

Last fiscal year, the FDA collected $573 million in user fees under the program, making up 62 percent of its total budget for prescription drug reviews. The portion of FDA's budget underwritten by industry has steadily increased since 1992, drawing criticism from consumer advocates that the agency has become financially dependent on the companies it regulates. Ten years ago the industry contributed about 49 percent of FDA's drug review budget.

Woodcock said the portion of FDA funding that comes from user fees is ultimately "up to Congress, and they can set it up however they want." She pointed out that some countries rely on user fees for 100 percent of their drug review budgets.

The increased private funding also has become a point of concern for some companies, which worry they could be asked to pay even more in fees if Congress cuts federal spending.

The Biotechnology Industry Organization endorsed the plan in a statement Thursday but stressed that Congress should continue funding the FDA at current levels.

"Industry has reinforced its commitment to a well-funded drug and biologics program that supports sound, science-based regulation," states BIO Chief Executive Jim Greenwood. "However, user fees are intended to support limited FDA activities around the drug review process and were never intended to supplant a sound base of appropriations."

Under the latest agreement, the FDA would be tasked with providing more meetings and updates to companies that have submitted first-of-a-kind drugs for review.

Separate but similar talks between the FDA and medical device makers are dragging out over a number of disagreements. Those companies have made shorter review times a priority, though the FDA says that goal will require significantly more funding, according to minutes from a recent meeting. FDA is hoping to reach an agreement in a few weeks, though "industry indicated it was more important to 'get it right' than to be finished by a certain date,'" according to the minutes.